IP Library Granted Patent US 7,919,626
Granted Patent B2
US 7,919,626 · App. 11/679,775 · Granted Apr 5, 2011

Pyrazole compounds and uses thereof

Assignee: Helicon Therapeutics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,919,626
App. No.
11/679,775
Granted
Apr 5, 2011
Kind
B2
Abstract

The invention provides a compound of formula I: wherein R 1 -R 6 , X, Y, and B have any of the values described herein, as well as salts of such compounds, compositions comprising such compounds, and therapeutic methods that comprise the administration of such compounds. The compounds are inhibitors of MAO-B enzyme function and are useful for improving cognitive function and for treating psychiatric disorders in animals.

Claims (2)

1. A compound selected from the group consisting of:

or a pharmaceutically acceptable salt thereof.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2012
From: DART NEUROSCIENCE LLC
To: DART NEUROSCIENCE (CAYMAN) LTD.
Reel/Frame 029361/0977 →
MERGER Recorded Nov 8, 2012
From: HELICON THERAPEUTICS, INC.
To: DART NEUROSCIENCE LLC
Reel/Frame 029293/0517 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2007
From: ZHOU, XIANBO; SCOTT, RODERICK E.M.; BOURTCHOULADZE, RUSIKO; KAPLAN, ALAN P.; KEENAN, TERENCE P.; MCRINER, ANDREW
To: HELICON THERAPEUTICS, INC.
Reel/Frame 019269/0627 →
Continuity (3)
Provisional Application 60777332 · Feb 28, 2006
Provisional Application 60890455 · Feb 16, 2007
Related Publication 20070203154A1 · Aug 30, 2007